RMTN Stock Overview
Rocky Mountain Ayre, Inc., through its subsidiaries, engages in food and hospitality, manufacturing, medical marijuana, and retail businesses.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rocky Mountain Ayre, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.041 |
52 Week High | US$0.041 |
52 Week Low | US$0.0004 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | 168.21% |
3 Year Change | 305.00% |
5 Year Change | 710.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
RMTN | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 2.1% | 1.2% |
1Y | 168.2% | 3.6% | 24.7% |
Return vs Industry: RMTN exceeded the US Healthcare industry which returned 3.2% over the past year.
Return vs Market: RMTN exceeded the US Market which returned 18.6% over the past year.
Price Volatility
RMTN volatility | |
---|---|
RMTN Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RMTN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RMTN's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | Greg Sullivan | www.rockymountainayre.com |
Rocky Mountain Ayre, Inc., through its subsidiaries, engages in food and hospitality, manufacturing, medical marijuana, and retail businesses. It operates a restaurant located in Agawam, Massachusetts. The company was formerly known as AyreTrade, Inc. and changed its name to Rocky Mountain Ayre, Inc. in February 2015.
Rocky Mountain Ayre, Inc. Fundamentals Summary
RMTN fundamental statistics | |
---|---|
Market cap | US$3.42m |
Earnings (TTM) | -US$9.26m |
Revenue (TTM) | US$5.57k |
0.0x
P/S Ratio0.0x
P/E RatioIs RMTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RMTN income statement (TTM) | |
---|---|
Revenue | US$5.57k |
Cost of Revenue | US$0 |
Gross Profit | US$5.57k |
Other Expenses | US$9.26m |
Earnings | -US$9.26m |
Last Reported Earnings
Mar 31, 2003
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did RMTN perform over the long term?
See historical performance and comparison